Engineered Biomarkers for Point‐of‐Care Diagnostics
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503581 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Lu Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Critical Materials for Integrated Circuits, Shenzhen Polytechnic University, Shenzhen, 518055, China. Hauptthemen laut MEDLINE: Biomarkers, Point-of-Care Systems, Point-of-Care Testing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 183 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program, Jiangsu Province Key R&D Program.
Abstract (Originalsprache)
Early diagnosis is essential for managing diseases and improving patient outcomes. Traditional diagnostic biomarkers are often limited by inadequate sensitivity and specificity, vulnerability to external influences, and difficulties in early‐stage detection. Engineered biomarkers that integrate bioengineering, chemistry, and nanotechnology can amplify detection signals by exploiting disease‐associated characteristics. This approach overcomes the limitations of traditional biomarkers and enables early disease diagnosis. Combining point‐of‐care (POC) platforms with engineered biomarkers offers rapid results for timely medical decision‐making. Additionally, the portability of POC platforms enables their use in various settings, including clinics, emergency rooms, and homes, enhancing accessibility for patients in remote areas or those with limited mobility. This platform can also streamline the detection process and reduce the complexity of traditional diagnostic procedures. This review explores the latest design advancements and applications of engineered biomarkers for various diseases from the perspective of POC detection methods. It thoroughly examines how these biomarkers improve the sensitivity and specificity of diagnostic techniques, the challenges of clinical transformation, and future research directions. This article aims to inspire the development of more advanced POC detection platforms for engineered biomarkers, promoting their application in future disease diagnostics and advancing personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Critical Materials for Integrated Circuits, Shenzhen Polytechnic University, Shenzhen, 518055, China.
- College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, 210023, China.
ORCID-Profile: Yujun Song
Förderung
- National Natural Science Foundation of China
- National Key R&D Program
- Jiangsu Province Key R&D Program
- State Key Laboratory of Analytical Chemistry for Life Science
- Postdoctoral Foundation Project of Shenzhen Polytechnic University
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, L., Zhou, D., Teng, C., & Song, Y. (2026). Engineered Biomarkers for Point‐of‐Care Diagnostics. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503581
Vancouver
Wang L, Zhou D, Teng C, Song Y. Engineered Biomarkers for Point‐of‐Care Diagnostics. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503581
BibTeX
@article{Wang2026,
author = {Wang, Lu and Zhou, Dongtao and Teng, Chao and Song, Yujun},
title = {Engineered Biomarkers for Point‐of‐Care Diagnostics},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503581}
}
EUVIMED